Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 2
1987 2
1988 3
1989 1
1990 3
1991 1
1992 2
1993 2
1994 7
1995 4
1996 4
1997 1
1998 3
1999 1
2000 1
2001 5
2002 4
2003 3
2004 5
2005 3
2006 4
2007 2
2008 8
2009 2
2010 8
2011 9
2012 5
2013 10
2014 5
2015 14
2016 14
2017 10
2018 13
2019 7
2020 15
2021 18
2022 19
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
Jost ST, Kaldenbach MA, Antonini A, Martinez-Martin P, Timmermann L, Odin P, Katzenschlager R, Borgohain R, Fasano A, Stocchi F, Hattori N, Kukkle PL, Rodríguez-Violante M, Falup-Pecurariu C, Schade S, Petry-Schmelzer JN, Metta V, Weintraub D, Deuschl G, Espay AJ, Tan EK, Bhidayasiri R, Fung VSC, Cardoso F, Trenkwalder C, Jenner P, Ray Chaudhuri K, Dafsari HS; International Parkinson and Movement Disorders Society Non-Motor Parkinson Disease Study Group. Jost ST, et al. Among authors: odin p. Mov Disord. 2023 Jul;38(7):1236-1252. doi: 10.1002/mds.29410. Epub 2023 May 5. Mov Disord. 2023. PMID: 37147135
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Among authors: odin p. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
Is levodopa toxic?
Müller T, Hefter H, Hueber R, Jost WH, Leenders KL, Odin P, Schwarz J. Müller T, et al. Among authors: odin p. J Neurol. 2004 Sep;251 Suppl 6:VI/44-6. doi: 10.1007/s00415-004-1610-x. J Neurol. 2004. PMID: 15675725 Review.
Diagnostic work up: Laboratory and biomarkers.
Cedergren Weber G, Odin P. Cedergren Weber G, et al. Among authors: odin p. Int Rev Neurobiol. 2022;162:53-96. doi: 10.1016/bs.irn.2021.12.003. Epub 2022 Jan 21. Int Rev Neurobiol. 2022. PMID: 35397789
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
Antonini A, Pahwa R, Odin P, Isaacson SH, Merola A, Wang L, Kandukuri PL, Alobaidi A, Yan CH, Bao Y, Zadikoff C, Parra JC, Bergmann L, Chaudhuri KR. Antonini A, et al. Among authors: odin p. CNS Drugs. 2022 Dec;36(12):1269-1283. doi: 10.1007/s40263-022-00963-9. Epub 2022 Nov 21. CNS Drugs. 2022. PMID: 36414908 Free PMC article.
Parkinson's disease: the non-motor issues.
Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Chaudhuri KR, et al. Among authors: odin p. Parkinsonism Relat Disord. 2011 Dec;17(10):717-23. doi: 10.1016/j.parkreldis.2011.02.018. Epub 2011 Jul 8. Parkinsonism Relat Disord. 2011. PMID: 21741874 Review.
223 results